Ousseny Zerbo to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Ousseny Zerbo has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.239
-
Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants. Pediatrics. 2025 Aug 01; 156(2).
Score: 0.239